28199934|t|Mixed corticomedullary adrenal carcinoma - case report: Comparison in features, treatment and prognosis with the other two reported cases
28199934|a|Adrenal corticomedullary adenoma was reviewed in many cases in PubMed Library, While the coincidence corticomedullary adrenal carcinoma in the same gland was just described in two cases in the medical literature. Our case is the third to be reported and was treated with surgery and adjuvant chemotherapy and followed for two years. A 50- year -old man suffered from a mass effect in the left abdominal side. While the laboratory showed a mild elevation in the levels of both serum cortisol and 24h urine cortisol, radiological images were highly suggested an adrenal malignant tumor without metastasis. At surgery a 22cm sized mass was completely resected. Immunohistochemical study identified expression of both adrenocortical carcinoma and pheochromocytoma markers. Cases of coincidence corticomedullary tumor have been published in many reviews, cortical and/or medulllary hypersecretion were not always detected preoperatively by biochemical tests. Mixed corticomedullary carcinoma are exceedingly rare, we came across three reported cases in medical literature, in one case laboratory tests confirmed both cortical and medulla hypersecretion, while the two others detected only cortical hypersecretion. The final diagnosis was always confirmed by immunohistochemical staining. It could be noted that this is the first comparison of presentation, diagnosis, treatments and follow-up of the three cases of Mixed corticomedullary carcinoma. This could contribute to understanding the behavior and management of this rare malignancy and make it more familiar in clinical practice.
28199934	6	22	corticomedullary	T023	C0927224
28199934	23	40	adrenal carcinoma	T191	C0206686
28199934	43	54	case report	T170	C0085973
28199934	56	66	Comparison	T052	C1707455
28199934	70	78	features	T080	C2348519
28199934	80	89	treatment	T169	C1522326
28199934	94	103	prognosis	T058	C0033325
28199934	132	137	cases	T169	C0868928
28199934	138	162	Adrenal corticomedullary	T030	C0229567
28199934	163	170	adenoma	T191	C0001430
28199934	175	183	reviewed	T080	C1709940
28199934	192	197	cases	T169	C0868928
28199934	201	215	PubMed Library	T170	C1138432
28199934	239	255	corticomedullary	T023	C0927224
28199934	256	273	adrenal carcinoma	T191	C0206686
28199934	286	291	gland	T023	C0001625
28199934	301	310	described	T078	C1552738
28199934	318	323	cases	T169	C0868928
28199934	331	349	medical literature	T078	C0025120
28199934	355	359	case	T169	C0868928
28199934	396	403	treated	T169	C1522326
28199934	409	416	surgery	T061	C0543467
28199934	421	442	adjuvant chemotherapy	T061	C0085533
28199934	464	469	years	T079	C0439234
28199934	477	481	year	T079	C0439234
28199934	487	490	man	T032	C0086582
28199934	507	518	mass effect	T033	C4086564
28199934	526	545	left abdominal side	T023	C1562302
28199934	557	567	laboratory	T059	C0022885
28199934	577	591	mild elevation	T082	C0702240
28199934	599	605	levels	T080	C0441889
28199934	614	628	serum cortisol	T059	C0236396
28199934	637	651	urine cortisol	T059	C1271705
28199934	653	672	radiological images	T170	C1704254
28199934	685	694	suggested	T078	C1705535
28199934	698	721	adrenal malignant tumor	T191	C0750887
28199934	730	740	metastasis	T046	C4255448
28199934	745	752	surgery	T061	C0543467
28199934	760	765	sized	T082	C0456389
28199934	766	770	mass	T033	C3273930
28199934	786	794	resected	T080	C1521996
28199934	796	815	Immunohistochemical	T060	C0021044
28199934	852	876	adrenocortical carcinoma	T191	C0206686
28199934	881	897	pheochromocytoma	T191	C0031511
28199934	898	905	markers	T201	C0005516
28199934	907	912	Cases	T169	C0868928
28199934	928	944	corticomedullary	T023	C0927224
28199934	945	950	tumor	T191	C0027651
28199934	961	970	published	T170	C0282411
28199934	988	996	cortical	T047	C1389845
28199934	1004	1029	medulllary hypersecretion	T047	C1386491
28199934	1046	1054	detected	T033	C0442726
28199934	1055	1069	preoperatively	T079	C0445204
28199934	1073	1090	biochemical tests	T059	C0430027
28199934	1098	1114	corticomedullary	T023	C0927224
28199934	1115	1124	carcinoma	T191	C0007097
28199934	1129	1145	exceedingly rare	T080	C0522498
28199934	1177	1182	cases	T169	C0868928
28199934	1186	1204	medical literature	T078	C0025120
28199934	1218	1234	laboratory tests	T059	C0022885
28199934	1235	1244	confirmed	T080	C0521093
28199934	1250	1258	cortical	T047	C1389845
28199934	1263	1285	medulla hypersecretion	T047	C1386491
28199934	1308	1316	detected	T033	C0442726
28199934	1322	1345	cortical hypersecretion	T047	C1389845
28199934	1357	1366	diagnosis	T062	C1704656
28199934	1378	1390	confirmed by	T080	C0521093
28199934	1391	1419	immunohistochemical staining	T059	C1508788
28199934	1462	1472	comparison	T052	C1707455
28199934	1476	1488	presentation	T078	C0449450
28199934	1490	1499	diagnosis	T080	C1704338
28199934	1501	1511	treatments	T169	C1522326
28199934	1539	1544	cases	T169	C0868928
28199934	1554	1570	corticomedullary	T023	C0927224
28199934	1571	1580	carcinoma	T191	C0007097
28199934	1625	1633	behavior	T169	C0474325
28199934	1638	1648	management	T058	C0376636
28199934	1662	1672	malignancy	T191	C4282132
28199934	1702	1719	clinical practice	T062	C0008972